Risk of Inability to Recover R&D Investments
First written in FY2018. 2 of 3 entries say "Restated". Latest entry: FY2020.
The whole theme swung hardest in 2026: 14 of 29 companies on the "Worse" side.
74 other companies' latest entry also says "Restated".
- FY2020RestatedAnnual report
「If market needs change substantially beyond the expectations of the Group, if products under development cannot be commercialized in a timely manner to meet market needs, or if research and development expenses increase significantly beyond initial expectations, the Group may be unable to recover its research and development investment, which could affect its operating results and financial position.」
The company continues to disclose the risk of failing to recover its investment because of changes in market needs, delays in commercialization, and higher research and development expenses. - FY2019RestatedAnnual report
「If market needs change substantially beyond the expectations of the Group, if products under development cannot be commercialized in a timely manner to meet market needs, or if research and development expenses increase significantly beyond initial expectations, the Group may be unable to recover its research and development investment, which could affect its operating results and financial position.」
The company continues to identify the risk of failing to recover its investment because of changes in market needs, the timing of commercialization, and higher research and development expenses. - FY2018First statedAnnual report
「If market needs change substantially beyond the expectations of the Group, if products under development cannot be commercialized in a timely manner to meet market needs, or if research and development expenses increase significantly beyond initial expectations, the Group may be unable to recover its research and development investment, which could affect its operating results and financial position.」
The company discloses the risk of failing to recover its investment because of higher research and development expenses, delays in commercialization, or a mismatch with market needs.